Pulmonary Hypertension Screening in Patients with Interstitial Lung Disease for Earlier Detection
(PHINDER Trial)
Recruiting in Palo Alto (17 mi)
+41 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Recruiting
Sponsor: United Therapeutics
No Placebo Group
Trial Summary
What is the purpose of this trial?
Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
Research Team
Eligibility Criteria
Inclusion Criteria
Patient gives voluntary written informed consent to participate in the study.
Idiopathic interstitial pneumonia, including idiopathic pulmonary fibrosis
Connective tissue disease-associated ILD with forced vital capacity (FVC) <70%
See 7 more
Treatment Details
Interventions
- Right heart catheterization (RHC) (Procedure)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Experimental study armExperimental Treatment1 Intervention
All enrolled patients in this single arm study will receive a RHC.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Piedmont HealthcareAustell, GA
University of South Florida HealthTampa, FL
Northwestern UniversityChicago, IL
University of Michigan Int Med Pulmonary and Critical CareAnn Arbor, MI
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
United Therapeutics
Lead Sponsor
Trials
112
Patients Recruited
14,500+